American Bio Medica

American Bio Medica Current Assets

Delisted

The Current Assets of American Bio Medica (ABMC) as of Nov 20, 2026 is 769,000.00 USD. In the previous year, Current Assets was 1.34 M USD — a change of -42.61% (lower).

Current Assets

769,000.00USD

YoY

-42.61%

Last updated:

Current Assets of American Bio Medica is 2022 769,000.00 USD. Current Assets of American Bio Medica was 2021 1.34 M USD. It decreases by -42.61% lower compared to the previous year.

The American Bio Medica Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2015
2.62 M USD
Jan 1, 2016
2.39 M USD
Jan 1, 2017
1.95 M USD
Jan 1, 2018
1.61 M USD
Jan 1, 2019
1.22 M USD
Jan 1, 2020
1.18 M USD
Jan 1, 2021
1.34 M USD
Jan 1, 2022
769,000.00 USD
The American Bio Medica Current Assets history
YEARCurrent AssetsYoY
769,000.00USD-42.61%
1.34 MUSD+13.56%
1.18 MUSD-3.59%
1.22 MUSD-24.12%
1.61 MUSD-17.45%
1.95 MUSD-18.11%
2.39 MUSD-8.79%
2.62 MUSD-13.26%
3.02 MUSD-19.57%
3.75 MUSD+6.53%
3.52 MUSD-17.56%
4.27 MUSD-5.11%
4.50 MUSD-14.77%
5.28 MUSD-24.68%
7.01 MUSD+1.89%
6.88 MUSD-1.29%
6.97 MUSD+9.42%
6.37 MUSD-2.30%
6.52 MUSD+22.33%
5.33 MUSD+27.21%
4.19 MUSD+19.03%
3.52 MUSD+16.17%
3.03 MUSD-20.47%
3.81 MUSD+0.26%
3.80 MUSD-23.39%
4.96 MUSD+26.21%
3.93 MUSD+702.04%
490,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

American Bio Medica Stock analysis

What does American Bio Medica do? American Bio Medica Corp is a US-based company specializing in the development and manufacture of drug testing devices and diagnostic products. The company was founded in 1986 and is headquartered in Kinderhook, New York. Its business model involves developing and producing drug testing devices and diagnostic products used by government agencies, companies, and private customers worldwide. The company also operates a laboratory that conducts diagnostic tests for third parties. Its five business areas include drug tests, medication safety, diagnostics, biometrics, and forensics. The company's products include urine, saliva, and sweat drug tests, as well as medical devices to prevent prescription drug abuse and diagnostic products for various diseases. It also offers biometric instruments and systems for person identification and forensic products for crime investigation. American Bio Medica Corp has been publicly traded since 1992 and has received several awards for its products and innovations. The company is committed to research and development, quality assurance, and accuracy in its products. Overall, it is a leading company in the field of drug testing devices and diagnostic products and is expected to continue to evolve in the future. American Bio Medica is one of the most popular companies on Eulerpool.

Frequently Asked Questions about American Bio Medica stock

Current Assets of American Bio Medica is 769,000.00 USD in 2022.

Current Assets of American Bio Medica changed from 1.34 M USD to 769,000.00 USD, representing a -42.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets American Bio Medica since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's American Bio Medica historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — American Bio Medica

All Key Metrics — American Bio Medica